ClinicalTrials.govpublic full text
Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
microsatellite stable metastatic colorectal cancer, evorpacept (alx148), cetuximab, pembrolizumab, crc, colorectal cancer, microsatellite stable, mss, cd47, sirpa, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 898958
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.